|
|
| Research article summary (published 23 Feb 2009): |
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
Full Abstract
We present a PD patient in whom dopamine agonists awoke a hidden creativity that led to a gradual increase in painting productivity evolving to a disruptive impulsive behaviour that shared many features with punding. A dramatic change in painting style related to a more emotional experience during the process of creation developed after treatment onset. This case suggests that changes in creativity in PD seem to be related to dopaminergic imbalance in the limbic system.
Author information
Author/s: Kulisevsky, Jaime (J); Pagonabarraga, Javier (J); Martinez-Corral, Mercè (M);
Affiliation: Movement Disorders Unit, Neurology Department, Sant Pau Hospital, Autonomous University of Barcelona, Sant Antoni Maria Claret 167, Barcelona 08025, Spain. jkulisevsky(-atsign-)santpau.es
Journal and publication information
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Journal: Journal of neurology (J Neurol), published in Germany. (Language: eng)
Reference: 2009-May; vol 256 (issue 5) : pp 816-9
Dates: Created 2009/05/19; Completed 2009/08/21;
PMID: 19240966, status: MEDLINE (last retrieved date: 8/21/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Antiparkinson Agents (0) ; Benzothiazoles (0) ; Dopamine Agonists (0) ; Ergolines (0) ; Levodopa (0) ; pramipexol (104632-26-0) ; cabergoline (81409-90-7)Related articles
These are the most related articles currently in our database:
- Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
30 Aug 2006 - Psychiatric sequelae of Parkinson disease: a case report.
29 Aug 2005 - Adjuncts to levodopa therapy: dopamine agonists.
30 May 1998 - The initial treatment of Parkinson's disease.
28 Feb 2000 - [High dosage therapy of Parkinson disease. New dopamine agonist pramipexol allows reduction of L-dopa dose down to zero]
30 Jul 1999 - Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
30 Oct 2004 - [Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy]
18 Feb 1997 - Treatment of Parkinson's disease should begin with a dopamine agonist.
28 Feb 2000 - Dopamine dysregulation syndrome in Parkinson's disease.
30 Jul 2004 - Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
30 Dec 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.